VANCOUVER – The Canadian company that helped develop the first antibody therapy treatment for COVID-19 is more than doubling the size of its planned expansion in Vancouver. AbCellera Biologics is announcing a new $700-million project today that will add research and development capacity to the manufacturing plant that has been in the works since 2020. … Continue reading B.C. company expands antibody research, production facilities for second time